Reflections on a Potential Federal Drug Formulary: Medicines Industry Response to CDA Consultation Policy Positions • July 22, 2025 Share View Topic Patented Medicine Prices Review Board (PMPRB) Pharmacare Tags Healthcare PMPRB research Value